Utility of algorithm-based chemoradioselection in the treatment for advanced hypopharyngeal carcinoma

Muneyuki Masuda, Mioko Matsuo, Takeichiro Aso, Hideyuki Kiyohara, Fumihide Rikimaru, Naonobu Kunitake, Yuichiro Higaki

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background Current organ-preserving dose-intensified modalities have apparently reached the limit of human tolerance. To optimize the therapeutic ratio, we evaluated the utility of a chemoradioselection strategy for the treatment of advanced hypopharyngeal carcinoma. Methods Fifty-five patients with advanced hypopharyngeal carcinoma were enrolled in our algorithm-based protocol. After 40 Gy of concurrent chemoradiation therapy (CCRT), patients who were chemoradioselected (chemoradioselected group, complete response [CR] at the primary site) received further 30 Gy of CCRT up to 70 Gy, whereas the remaining nonchemoradioselected (nonchemoradioselected group) patients underwent radical surgery. Results Based on this algorithm, 27 patients were chemoradioselected and 28 nonchemoradioselected. The 5-year cumulative disease-specific and overall survival (OS) rates were 76% and 65%, respectively. The chemoradioselected group demonstrated favorable laryngoesophageal dysfunction-free survival (77% at 3 years). Conclusion Although preliminary, our results indicate that algorithm-based chemoradioselection may provide a novel platform for improving the treatment of advanced hypopharyngeal carcinoma by providing the complete advantages of CCRT and radical surgical resection.

Original languageEnglish
Pages (from-to)1290-1296
Number of pages7
JournalHead and Neck
Volume37
Issue number9
DOIs
Publication statusPublished - Sep 1 2015

Fingerprint

Carcinoma
Therapeutics
Survival Rate
Survival

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Masuda, M., Matsuo, M., Aso, T., Kiyohara, H., Rikimaru, F., Kunitake, N., & Higaki, Y. (2015). Utility of algorithm-based chemoradioselection in the treatment for advanced hypopharyngeal carcinoma. Head and Neck, 37(9), 1290-1296. https://doi.org/10.1002/hed.23759

Utility of algorithm-based chemoradioselection in the treatment for advanced hypopharyngeal carcinoma. / Masuda, Muneyuki; Matsuo, Mioko; Aso, Takeichiro; Kiyohara, Hideyuki; Rikimaru, Fumihide; Kunitake, Naonobu; Higaki, Yuichiro.

In: Head and Neck, Vol. 37, No. 9, 01.09.2015, p. 1290-1296.

Research output: Contribution to journalArticle

Masuda, M, Matsuo, M, Aso, T, Kiyohara, H, Rikimaru, F, Kunitake, N & Higaki, Y 2015, 'Utility of algorithm-based chemoradioselection in the treatment for advanced hypopharyngeal carcinoma', Head and Neck, vol. 37, no. 9, pp. 1290-1296. https://doi.org/10.1002/hed.23759
Masuda, Muneyuki ; Matsuo, Mioko ; Aso, Takeichiro ; Kiyohara, Hideyuki ; Rikimaru, Fumihide ; Kunitake, Naonobu ; Higaki, Yuichiro. / Utility of algorithm-based chemoradioselection in the treatment for advanced hypopharyngeal carcinoma. In: Head and Neck. 2015 ; Vol. 37, No. 9. pp. 1290-1296.
@article{d9106362e4e240d3bbd7dc6d0c74624e,
title = "Utility of algorithm-based chemoradioselection in the treatment for advanced hypopharyngeal carcinoma",
abstract = "Background Current organ-preserving dose-intensified modalities have apparently reached the limit of human tolerance. To optimize the therapeutic ratio, we evaluated the utility of a chemoradioselection strategy for the treatment of advanced hypopharyngeal carcinoma. Methods Fifty-five patients with advanced hypopharyngeal carcinoma were enrolled in our algorithm-based protocol. After 40 Gy of concurrent chemoradiation therapy (CCRT), patients who were chemoradioselected (chemoradioselected group, complete response [CR] at the primary site) received further 30 Gy of CCRT up to 70 Gy, whereas the remaining nonchemoradioselected (nonchemoradioselected group) patients underwent radical surgery. Results Based on this algorithm, 27 patients were chemoradioselected and 28 nonchemoradioselected. The 5-year cumulative disease-specific and overall survival (OS) rates were 76{\%} and 65{\%}, respectively. The chemoradioselected group demonstrated favorable laryngoesophageal dysfunction-free survival (77{\%} at 3 years). Conclusion Although preliminary, our results indicate that algorithm-based chemoradioselection may provide a novel platform for improving the treatment of advanced hypopharyngeal carcinoma by providing the complete advantages of CCRT and radical surgical resection.",
author = "Muneyuki Masuda and Mioko Matsuo and Takeichiro Aso and Hideyuki Kiyohara and Fumihide Rikimaru and Naonobu Kunitake and Yuichiro Higaki",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/hed.23759",
language = "English",
volume = "37",
pages = "1290--1296",
journal = "Head and Neck Surgery",
issn = "1043-3074",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Utility of algorithm-based chemoradioselection in the treatment for advanced hypopharyngeal carcinoma

AU - Masuda, Muneyuki

AU - Matsuo, Mioko

AU - Aso, Takeichiro

AU - Kiyohara, Hideyuki

AU - Rikimaru, Fumihide

AU - Kunitake, Naonobu

AU - Higaki, Yuichiro

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background Current organ-preserving dose-intensified modalities have apparently reached the limit of human tolerance. To optimize the therapeutic ratio, we evaluated the utility of a chemoradioselection strategy for the treatment of advanced hypopharyngeal carcinoma. Methods Fifty-five patients with advanced hypopharyngeal carcinoma were enrolled in our algorithm-based protocol. After 40 Gy of concurrent chemoradiation therapy (CCRT), patients who were chemoradioselected (chemoradioselected group, complete response [CR] at the primary site) received further 30 Gy of CCRT up to 70 Gy, whereas the remaining nonchemoradioselected (nonchemoradioselected group) patients underwent radical surgery. Results Based on this algorithm, 27 patients were chemoradioselected and 28 nonchemoradioselected. The 5-year cumulative disease-specific and overall survival (OS) rates were 76% and 65%, respectively. The chemoradioselected group demonstrated favorable laryngoesophageal dysfunction-free survival (77% at 3 years). Conclusion Although preliminary, our results indicate that algorithm-based chemoradioselection may provide a novel platform for improving the treatment of advanced hypopharyngeal carcinoma by providing the complete advantages of CCRT and radical surgical resection.

AB - Background Current organ-preserving dose-intensified modalities have apparently reached the limit of human tolerance. To optimize the therapeutic ratio, we evaluated the utility of a chemoradioselection strategy for the treatment of advanced hypopharyngeal carcinoma. Methods Fifty-five patients with advanced hypopharyngeal carcinoma were enrolled in our algorithm-based protocol. After 40 Gy of concurrent chemoradiation therapy (CCRT), patients who were chemoradioselected (chemoradioselected group, complete response [CR] at the primary site) received further 30 Gy of CCRT up to 70 Gy, whereas the remaining nonchemoradioselected (nonchemoradioselected group) patients underwent radical surgery. Results Based on this algorithm, 27 patients were chemoradioselected and 28 nonchemoradioselected. The 5-year cumulative disease-specific and overall survival (OS) rates were 76% and 65%, respectively. The chemoradioselected group demonstrated favorable laryngoesophageal dysfunction-free survival (77% at 3 years). Conclusion Although preliminary, our results indicate that algorithm-based chemoradioselection may provide a novel platform for improving the treatment of advanced hypopharyngeal carcinoma by providing the complete advantages of CCRT and radical surgical resection.

UR - http://www.scopus.com/inward/record.url?scp=84938966552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938966552&partnerID=8YFLogxK

U2 - 10.1002/hed.23759

DO - 10.1002/hed.23759

M3 - Article

VL - 37

SP - 1290

EP - 1296

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 1043-3074

IS - 9

ER -